Charles Schwab Investment Management Inc Precision Biosciences Inc Transaction History

Charles Schwab Investment Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.22 - $40.8 $201,249 - $6.73 Million	-164,959 Reduced 76.29%	51,273 $67,000
Q2 2022 Aug 15, 2022	SELL	$1.15 - $3.34 $168,156 - $488,384	-146,223 Reduced 40.34%	216,232 $346,000
Q1 2022 May 13, 2022	BUY	$2.96 - $7.76 $38,027 - $99,692	12,847 Added 3.67%	362,455 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$7.4 - $11.66 $119,502 - $188,297	16,149 Added 4.84%	349,608 $2.59 Million
Q3 2021 Nov 16, 2021	BUY	$9.18 - $14.15 $144,107 - $222,126	15,698 Added 4.94%	333,459 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$8.07 - $12.52 $152,369 - $236,390	18,881 Added 6.32%	317,761 $3.98 Million
Q1 2021 May 17, 2021	BUY	$8.57 - $15.79 $56,339 - $103,803	6,574 Added 2.25%	298,880 $3.09 Million
Q4 2020 Feb 16, 2021	BUY	$5.98 - $12.47 $38,738 - $80,780	6,478 Added 2.27%	292,306 $2.44 Million
Q3 2020 Nov 13, 2020	BUY	$4.65 - $8.73 $729,775 - $1.37 Million	156,941 Added 121.77%	285,828 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$4.66 - $8.7 $94,714 - $176,827	20,325 Added 18.72%	128,887 $1.07 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $15.01 $1,696 - $5,043	336 Added 0.31%	108,562 $655,000
Q4 2019 Feb 07, 2020	BUY	$6.32 - $19.66 $364,632 - $1.13 Million	57,695 Added 114.18%	108,226 $1.5 Million
Q3 2019 Nov 08, 2019	BUY	$8.03 - $14.82 $19,978 - $36,872	2,488 Added 5.18%	50,531 $424,000
Q2 2019 Aug 09, 2019	BUY	$11.88 - $16.94 $570,750 - $813,848	48,043 New	48,043 $637,000

2.56M

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $539M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.